IL96696A - Process for the preparation of derivatives of 1-phenyl-imidazoline-2,5-dione - Google Patents

Process for the preparation of derivatives of 1-phenyl-imidazoline-2,5-dione

Info

Publication number: IL96696A
Authority: IL; Israel
Prior art keywords: radical; oxide; formula; phenyl; catalyst
Prior art date: 1989-12-22

Application number

IL9669690A

Other languages

English (en)

Other versions

IL96696A0 (en

Original Assignee

Roussel Uclaf

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-12-22

Filing date

1990-12-17

Publication date

1995-08-31

1990-12-17 Application filed by Roussel Uclaf filed Critical Roussel Uclaf

1991-09-16 Publication of IL96696A0 publication Critical patent/IL96696A0/xx

1995-08-31 Publication of IL96696A publication Critical patent/IL96696A/en

Links

238000000034 method Methods 0.000 title claims abstract description 24
238000002360 preparation method Methods 0.000 title claims abstract description 11
RUEGAVIENIPHGK-UHFFFAOYSA-N 3-phenylimidazolidine-2,4-dione Chemical class O=C1CNC(=O)N1C1=CC=CC=C1 RUEGAVIENIPHGK-UHFFFAOYSA-N 0.000 title 1
239000003054 catalyst Substances 0.000 claims abstract description 16
238000006243 chemical reaction Methods 0.000 claims abstract description 9
239000002904 solvent Substances 0.000 claims abstract description 8
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 5
125000000217 alkyl group Chemical group 0.000 claims abstract description 4
125000003342 alkenyl group Chemical group 0.000 claims abstract description 3
125000003302 alkenyloxy group Chemical group 0.000 claims abstract description 3
125000003545 alkoxy group Chemical group 0.000 claims abstract description 3
125000000304 alkynyl group Chemical group 0.000 claims abstract description 3
125000005843 halogen group Chemical group 0.000 claims abstract description 3
125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims abstract description 3
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract 2
-1 alkynyloxy radical Chemical class 0.000 claims description 30
YFNKIDBQEZZDLK-UHFFFAOYSA-N triglyme Chemical compound COCCOCCOCCOC YFNKIDBQEZZDLK-UHFFFAOYSA-N 0.000 claims description 10
125000004432 carbon atom Chemical group C* 0.000 claims description 9
BERDEBHAJNAUOM-UHFFFAOYSA-N copper(I) oxide Inorganic materials [Cu]O[Cu] BERDEBHAJNAUOM-UHFFFAOYSA-N 0.000 claims description 9
KRFJLUBVMFXRPN-UHFFFAOYSA-N cuprous oxide Chemical compound [O-2].[Cu+].[Cu+] KRFJLUBVMFXRPN-UHFFFAOYSA-N 0.000 claims description 9
229940112669 cuprous oxide Drugs 0.000 claims description 9
USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 claims description 9
239000002184 metal Substances 0.000 claims description 9
229910052751 metal Inorganic materials 0.000 claims description 9
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
229960001760 dimethyl sulfoxide Drugs 0.000 claims description 6
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 5
229910052802 copper Inorganic materials 0.000 claims description 5
239000010949 copper Substances 0.000 claims description 5
QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 claims description 4
WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical compound F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 claims description 4
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 4
229940072033 potash Drugs 0.000 claims description 4
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
235000015320 potassium carbonate Nutrition 0.000 claims description 4
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 3
SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 claims description 3
ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical compound O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 claims description 3
229940108928 copper Drugs 0.000 claims description 2
229960004643 cupric oxide Drugs 0.000 claims description 2
BLNWTAHYTCHDJH-UHFFFAOYSA-O hydroxy(oxo)azanium Chemical compound O[NH+]=O BLNWTAHYTCHDJH-UHFFFAOYSA-O 0.000 claims description 2
WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 claims description 2
150000003254 radicals Chemical class 0.000 claims description 2
125000001424 substituent group Chemical group 0.000 claims description 2
125000002252 acyl group Chemical group 0.000 abstract 1
125000005133 alkynyloxy group Chemical group 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
239000000047 product Substances 0.000 description 17
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
CFPIGEXZPWTNOR-UHFFFAOYSA-N 4-chloro-1-nitro-2-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C=C1C(F)(F)F CFPIGEXZPWTNOR-UHFFFAOYSA-N 0.000 description 5
YIROYDNZEPTFOL-UHFFFAOYSA-N 5,5-Dimethylhydantoin Chemical compound CC1(C)NC(=O)NC1=O YIROYDNZEPTFOL-UHFFFAOYSA-N 0.000 description 5
239000000203 mixture Substances 0.000 description 5
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
XWXYUMMDTVBTOU-UHFFFAOYSA-N nilutamide Chemical compound O=C1C(C)(C)NC(=O)N1C1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 XWXYUMMDTVBTOU-UHFFFAOYSA-N 0.000 description 3
238000004809 thin layer chromatography Methods 0.000 description 3
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
238000009835 boiling Methods 0.000 description 2
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
229960002653 nilutamide Drugs 0.000 description 2
239000000843 powder Substances 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
KKFDJZZADQONDE-UHFFFAOYSA-N (hydridonitrato)hydroxidocarbon(.) Chemical compound O[C]=N KKFDJZZADQONDE-UHFFFAOYSA-N 0.000 description 1
SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
125000006017 1-propenyl group Chemical group 0.000 description 1
125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
238000013019 agitation Methods 0.000 description 1
125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
125000005336 allyloxy group Chemical group 0.000 description 1
HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
235000011114 ammonium hydroxide Nutrition 0.000 description 1
125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
229910052794 bromium Inorganic materials 0.000 description 1
125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
125000001309 chloro group Chemical group Cl* 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000006482 condensation reaction Methods 0.000 description 1
239000012043 crude product Substances 0.000 description 1
239000013078 crystal Substances 0.000 description 1
238000001035 drying Methods 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
150000001469 hydantoins Chemical class 0.000 description 1
229910000039 hydrogen halide Inorganic materials 0.000 description 1
239000012433 hydrogen halide Substances 0.000 description 1
229910052740 iodine Inorganic materials 0.000 description 1
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
229910044991 metal oxide Inorganic materials 0.000 description 1
150000004706 metal oxides Chemical class 0.000 description 1
125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
229910052759 nickel Inorganic materials 0.000 description 1
239000012188 paraffin wax Substances 0.000 description 1
LEVJVKGPFAQPOI-UHFFFAOYSA-N phenylmethanone Chemical compound O=[C]C1=CC=CC=C1 LEVJVKGPFAQPOI-UHFFFAOYSA-N 0.000 description 1
UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
238000000746 purification Methods 0.000 description 1
239000012264 purified product Substances 0.000 description 1
239000012429 reaction media Substances 0.000 description 1
125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
229940099259 vaseline Drugs 0.000 description 1
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1
238000005406 washing Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Plural Heterocyclic Compounds (AREA)
Reinforced Plastic Materials (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Photoreceptors In Electrophotography (AREA)
Compositions Of Macromolecular Compounds (AREA)

IL9669690A 1989-12-22 1990-12-17 Process for the preparation of derivatives of 1-phenyl-imidazoline-2,5-dione IL96696A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR8917046A FR2656302B1 (fr)	1989-12-22	1989-12-22	Nouveau procede de preparation de l'anandron et derives de l'anandron.

Publications (2)

Publication Number	Publication Date
IL96696A0 IL96696A0 (en)	1991-09-16
IL96696A true IL96696A (en)	1995-08-31

Family

ID=9388859

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL9669690A IL96696A (en)	1989-12-22	1990-12-17	Process for the preparation of derivatives of 1-phenyl-imidazoline-2,5-dione

Country Status (24)

Country	Link
US (1)	US5166358A (de)
EP (1)	EP0436426B1 (de)
JP (1)	JP2836041B2 (de)
KR (1)	KR0173307B1 (de)
CN (1)	CN1048011C (de)
AT (1)	ATE107289T1 (de)
AU (1)	AU628699B2 (de)
CA (1)	CA2032988C (de)
CZ (1)	CZ281655B6 (de)
DE (1)	DE69009964T2 (de)
DK (1)	DK0436426T3 (de)
ES (1)	ES2055382T3 (de)
FI (1)	FI103203B (de)
FR (1)	FR2656302B1 (de)
HU (1)	HU207301B (de)
IE (1)	IE65510B1 (de)
IL (1)	IL96696A (de)
NZ (1)	NZ236621A (de)
PL (1)	PL164694B1 (de)
PT (1)	PT96313B (de)
RU (1)	RU1836356C (de)
SK (1)	SK278447B6 (de)
UA (1)	UA27220C2 (de)
ZA (1)	ZA909648B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5411981A (en) *	1991-01-09	1995-05-02	Roussel Uclaf	Phenylimidazolidines having antiandrogenic activity
FR2693461B1 (fr) *	1992-07-08	1994-09-02	Roussel Uclaf	Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
FR2694290B1 (fr) *	1992-07-08	1994-09-02	Roussel Uclaf	Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
US5656651A (en) *	1995-06-16	1997-08-12	Biophysica Inc.	Androgenic directed compositions
DE19540027A1 (de) *	1995-10-27	1997-04-30	Gruenenthal Gmbh	Substituierte Imidazolidin-2,4-dion-Verbindungen als pharmazeutische Wirkstoffe
FR2741346B1 (fr) *	1995-11-16	1997-12-19	Roussel Uclaf	Nouveau procede de preparation de derives phenylimidazolidine
FR2741342B1 (fr) *	1995-11-22	1998-02-06	Roussel Uclaf	Nouvelles phenylimidazolidines fluorees ou hydroxylees, procede, intermediaires de preparation, application comme medicaments, nouvelle utilisation et compositions pharmaceutiques
JPH1072446A (ja) *	1996-06-24	1998-03-17	Sumitomo Chem Co Ltd	１−置換−ヒダントイン類の製造法
US20040077605A1 (en)	2001-06-20	2004-04-22	Salvati Mark E.	Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US7001911B2 (en)	2000-06-28	2006-02-21	Bristol-Myers Squibb Company	Fused cyclic modulators of nuclear hormone receptor function
MXPA02012605A (es) *	2000-06-28	2003-05-14	Squibb Bristol Myers Co	Moduladores selectivos del receptor androgeno y metodo para su identificacion, dise°o y uso.
EP1854798A3 (de)	2000-09-19	2007-11-28	Bristol-Myers Squibb Company	Kondensierte heterozyklische Succinimid-Verbindungen und Analoga daraus, Modulatoren der nuklearen Hormonrezeptorfunktion
US6953679B2 (en)	2000-09-19	2005-10-11	Bristol-Myers Squibb Company	Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
US20040087548A1 (en)	2001-02-27	2004-05-06	Salvati Mark E.	Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US7087636B2 (en)	2001-12-19	2006-08-08	Bristol-Myers Squibb Company	Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
ATE502298T1 (de) *	2003-12-19	2011-04-15	Univ California	Verfahren und materialien zur beurteilung von prostatakrebstherapien
NZ550102A (en) *	2004-02-24	2010-10-29	Univ California	Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
US7709517B2 (en)	2005-05-13	2010-05-04	The Regents Of The University Of California	Diarylhydantoin compounds
SI2656842T1 (sl)	2006-03-27	2016-10-28	The Regents Of The University Of California	Modulator androgenih receptorjev za zdravljenje raka prostate in bolezni, povezanih z androgenimi receptorji
WO2007127010A2 (en)	2006-03-29	2007-11-08	The Regents Of The University Of California	Diarylthiohydantoin compounds
EP2620432A3 (de)	2007-10-26	2013-12-18	The Regents Of the University of California	Diarylhydantoinverbindungen
AU2011218173C1 (en)	2010-02-16	2015-04-16	Aragon Pharmaceuticals, Inc.	Androgen receptor modulators and uses thereof
NZ744456A (en)	2012-09-26	2019-09-27	Aragon Pharmaceuticals Inc	Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
PL2945628T3 (pl)	2013-01-15	2020-09-21	Aragon Pharmaceuticals, Inc.	Modulator receptorów androgenowych w skojarzeniu z octanem abirateronu i prednizonem do leczenia nowotworu stercza
TWI726969B (zh)	2016-01-11	2021-05-11	比利時商健生藥品公司	用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
US10702508B2 (en)	2017-10-16	2020-07-07	Aragon Pharmaceuticals, Inc.	Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH166004A (de) *	1934-06-06	1933-12-15	Chem Fab Vormals Sandoz	Verfahren zur Darstellung eines Derivates des 5,5-Phenyläthylhydantoins.
US2490813A (en) *	1944-11-29	1949-12-13	Standard Oil Co	Continuous process for making aryl amines
US2759002A (en) *	1954-03-24	1956-08-14	Abbott Lab	3-benzyl hydantoin and process
US3134663A (en) *	1957-07-23	1964-05-26	Geigy Chem Corp	Herbicidal composition and method employing hydantoins
US3914311A (en) *	1973-06-15	1975-10-21	Du Pont	Preparation of aromatic secondary and tertiary amines using a nickel complex catalyst
DE2414613A1 (de) *	1974-03-26	1975-10-16	Bayer Ag	1-aryl-5-alkyliden-2,4-dioxo-imidazolidine
FR2329276A1 (fr) *	1975-10-29	1977-05-27	Roussel Uclaf	Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant
IL55774A (en) *	1977-10-28	1982-04-30	Sparamedica Ag	Pharmaceutical compositions containing urea derivatives,certain such novel derivatives and their manufacture
GB1598166A (en) *	1978-05-23	1981-09-16	Lilly Industries Ltd	3,5-disubstituted hydantoin derivatives
US4764625A (en) *	1980-12-12	1988-08-16	Xerox Corporation	Process for preparing arylamines
EP0091596B1 (de) *	1982-04-08	1991-09-11	Shell Internationale Researchmaatschappij B.V.	Neue Hydantoine, ihre Herstellung und Verwendung

1989
- 1989-12-22 FR FR8917046A patent/FR2656302B1/fr not_active Expired - Fee Related
1990
- 1990-11-16 IE IE414290A patent/IE65510B1/en not_active IP Right Cessation
- 1990-11-30 ZA ZA909648A patent/ZA909648B/xx unknown
- 1990-12-10 JP JP2407176A patent/JP2836041B2/ja not_active Expired - Lifetime
- 1990-12-17 IL IL9669690A patent/IL96696A/en not_active IP Right Cessation
- 1990-12-18 US US07/629,490 patent/US5166358A/en not_active Expired - Lifetime
- 1990-12-20 PL PL90288365A patent/PL164694B1/pl unknown
- 1990-12-20 AU AU68265/90A patent/AU628699B2/en not_active Expired
- 1990-12-21 DE DE69009964T patent/DE69009964T2/de not_active Expired - Lifetime
- 1990-12-21 AT AT90403725T patent/ATE107289T1/de not_active IP Right Cessation
- 1990-12-21 CA CA002032988A patent/CA2032988C/fr not_active Expired - Lifetime
- 1990-12-21 FI FI906366A patent/FI103203B/fi active IP Right Grant
- 1990-12-21 SK SK6567-90A patent/SK278447B6/sk not_active IP Right Cessation
- 1990-12-21 EP EP90403725A patent/EP0436426B1/de not_active Expired - Lifetime
- 1990-12-21 HU HU908416A patent/HU207301B/hu unknown
- 1990-12-21 KR KR1019900021357A patent/KR0173307B1/ko not_active Expired - Lifetime
- 1990-12-21 ES ES90403725T patent/ES2055382T3/es not_active Expired - Lifetime
- 1990-12-21 NZ NZ236621A patent/NZ236621A/en unknown
- 1990-12-21 CZ CS906567A patent/CZ281655B6/cs not_active IP Right Cessation
- 1990-12-21 UA UA4894040A patent/UA27220C2/uk unknown
- 1990-12-21 PT PT96313A patent/PT96313B/pt not_active IP Right Cessation
- 1990-12-21 DK DK90403725.6T patent/DK0436426T3/da active
- 1990-12-21 RU SU904894040A patent/RU1836356C/ru active
- 1990-12-22 CN CN90110071A patent/CN1048011C/zh not_active Expired - Lifetime

Also Published As

Publication number	Publication date
IL96696A0 (en)	1991-09-16
JPH04103573A (ja)	1992-04-06
CZ656790A3 (en)	1996-08-14
AU628699B2 (en)	1992-09-17
CA2032988A1 (fr)	1991-06-23
PL288365A1 (en)	1991-09-09
KR0173307B1 (ko)	1999-02-01
PT96313A (pt)	1991-09-30
FR2656302B1 (fr)	1992-05-07
ATE107289T1 (de)	1994-07-15
FI103203B1 (fi)	1999-05-14
RU1836356C (ru)	1993-08-23
HU207301B (en)	1993-03-29
HU908416D0 (en)	1991-07-29
CA2032988C (fr)	2003-04-29
EP0436426A1 (de)	1991-07-10
SK656790A3 (en)	1997-06-04
DE69009964D1 (de)	1994-07-21
FR2656302A1 (fr)	1991-06-28
DK0436426T3 (da)	1994-07-04
US5166358A (en)	1992-11-24
DE69009964T2 (de)	1994-10-13
PT96313B (pt)	1998-06-30
IE65510B1 (en)	1995-11-01
CZ281655B6 (cs)	1996-12-11
JP2836041B2 (ja)	1998-12-14
AU6826590A (en)	1991-06-27
IE904142A1 (en)	1991-07-03
UA27220C2 (uk)	2000-08-15
FI906366A0 (fi)	1990-12-21
CN1052666A (zh)	1991-07-03
CN1048011C (zh)	2000-01-05
EP0436426B1 (de)	1994-06-15
ES2055382T3 (es)	1994-08-16
FI906366L (fi)	1991-06-23
FI103203B (fi)	1999-05-14
KR910011799A (ko)	1991-08-07
SK278447B6 (en)	1997-06-04
ZA909648B (en)	1992-02-26
PL164694B1 (pl)	1994-09-30
NZ236621A (en)	1992-04-28

Legal Events

Date	Code	Title
1997-03-18	KB	Patent renewed
2000-06-01	HCE	Change of name and address of proprietor(s)
2001-06-14	KB	Patent renewed
2003-01-12	HCA	Change of name of proprietor(s) after amalgamation
2005-02-20	KB	Patent renewed
2009-06-15	KB	Patent renewed
2011-07-31	EXP	Patent expired

Publication	Publication Date	Title
IL96696A (en)	1995-08-31	Process for the preparation of derivatives of 1-phenyl-imidazoline-2,5-dione
FR2492383A1 (fr)	1982-04-23	Halogenures d'ammonium spiro-quaternaire, leur procede de prepatation et leur utilisation dans un procede de production de n-(2-pyrimidinyl) piperazinyl-alkylazospiro-alcanediones
JPH05320145A (ja)	1993-12-03	トリアジン誘導体の製造方法
JPH05262749A (ja)	1993-10-12	６−トリフルオロメチル−１，３，５トリアジン誘導体の製造方法
US6172230B1 (en)	2001-01-09	Process for the preparation of tetrahydro-indolizines
CA1331602C (en)	1994-08-23	Preparation process of acemetacin
US4560764A (en)	1985-12-24	Synthesis of an imidazolyl isothiourea
EP0693482B1 (de)	2001-09-12	Verfahren zur herstellung von hexahydropyridazin und hexahydropyridazin-1,2-dicarboxylat-derivaten
US4281125A (en)	1981-07-28	Quinoline catalyzed synthesis of pyridazinone pharmaceutical intermediates
CA1048024A (en)	1979-02-06	Triazino (4,3-d) (1,4) benzodiazepine-3,4,7-triones
US4289897A (en)	1981-09-15	Method for production of acylhydrazones of formyl-acetic acid ester
EP0621260B1 (de)	1997-02-05	Verfahren zur Herstellung von ein N,N-disubstituiertes p-Phenylendiamine sulfat Derivate
US4286091A (en)	1981-08-25	Synthesis of pyridazinone pharmaceutical intermediates using diketene reactant
US4537730A (en)	1985-08-27	Preparation of O,S-dimethyl-thiolophosphoric acid amide
PL98602B1 (pl)	1978-05-31	Sposob wytwarzania 5-(/1-hydroksy-1-metylo-/etylo)-1-metylo-2-nitroimidazolu
US4099009A (en)	1978-07-04	1-(4-chlorophenyl)-3-(1-ureido)-2-imidazolidinone
HU213387B (en)	1997-05-28	2-substituted-5-chlor-imidazole-derivatives and process for their preparation
JP2536756B2 (ja)	1996-09-18	５−アルコキシアントラニル酸エステル
EP0041576A1 (de)	1981-12-16	1-(2,6-dichlorphenyl)-2-chinolinon-imin-3-carbonsäure, herstellung der verbindung und sie enthaltende schmerzstillende, entzündungsverhütende zusammensetzung
IE73669B1 (en)	1997-07-02	Process for the preparation of aminotriazine derivatives
JPH07224043A (ja)	1995-08-22	ヘキサヒドロピリダジンの製造法
JPS61233676A (ja)	1986-10-17	２−メチル−３−カルボン酸アミドキノキサリン−１，４−ジ−ｎ−オキシドの新規な製造法
PL91509B1 (de)	1977-02-28
JPH0725769B2 (ja)	1995-03-22	水溶性トリアゾロベンゾチアゾール誘導体またはその塩